Today it was reported that the EVP, Comp. Animal Health Sales of Heska Corp (NASDAQ: HSKA), Steve Asakowicz, exercised options to sell 8,000 HSKA shares at $37.21 a share, for a total transaction value of $808.2K.
Following Steve Asakowicz’s last HSKA Sell transaction on June 01, 2017, the stock climbed by 2.1%. In addition to Steve Asakowicz, 2 other HSKA executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
HSKA’s market cap is $751.6M and the company has a P/E ratio of 128.13. Currently, Heska Corp has an average volume of 44.3K.
Based on 4 analyst ratings, the analyst consensus is Strong Buy with an average price target of $110.25, reflecting a 11.7% upside.
The insider sentiment on Heska Corp has been negative according to 33 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the Core Companion Animal Health; and Other Vaccines, and Pharmaceuticals and Products segments.
